Accelerate Diagnostics Inc PEG
Was ist das PEG von Accelerate Diagnostics Inc?
PEG von Accelerate Diagnostics Inc ist N/A
Was ist die Definition von PEG?
Das Kurs-Gewinn-Wachstums-Verhältnis (PEG) ist das KGV einer Aktie geteilt durch eine erwartete Wachstumsrate des Gewinns über einen Zeitraum von 5 Jahren.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Accelerate Diagnostics Inc
Was macht Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Unternehmen mit peg ähnlich Accelerate Diagnostics Inc
- Leju Ltd hat PEG von N/A
- Stuart Olson hat PEG von N/A
- Castlight Health Inc hat PEG von N/A
- Nava Bharat Ventures hat PEG von N/A
- CYREN Ltd hat PEG von N/A
- Radius Recycling hat PEG von N/A
- Accelerate Diagnostics Inc hat PEG von N/A
- Ternium S.A hat PEG von N/A
- CBL& Associates Properties hat PEG von N/A
- Intellia Therapeutics Inc hat PEG von N/A
- Flotek Industries Inc hat PEG von N/A
- Beasley Broadcast Inc hat PEG von N/A
- Kosmos hat PEG von N/A